TreeWAS – Variant ID: rs4143844

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D23.1 Skin of eyelid, including canthus	0.030	0.970	0.000
K61.0 Anal abscess	0.013	0.987	0.000
N18.5 Chronic kidney disease, stage 5	0.013	0.987	0.000
N18.9 Chronic renal failure, unspecified	0.011	0.989	0.000
N18 Chronic renal failure	0.010	0.990	0.000
N18.0 End-stage renal disease	0.009	0.991	0.000
K61 Abscess of anal and rectal regions	0.008	0.992	0.000
R20.2 Paraesthesia of skin	0.008	0.992	0.000
N18.1 Chronic kidney disease, stage 1	0.007	0.993	0.000
N18.8 Other chronic renal failure	0.007	0.993	0.000
K61.1 Rectal abscess	0.007	0.993	0.000
N18.4 Chronic kidney disease, stage 4	0.007	0.993	0.000
K61.3 Ischiorectal abscess	0.006	0.994	0.000
K61.4 Intrasphincteric abscess	0.006	0.994	0.000
K61.2 Anorectal abscess	0.006	0.994	0.000
N18.2 Chronic kidney disease, stage 2	0.006	0.994	0.000
N18.3 Chronic kidney disease, stage 3	0.006	0.994	0.000
N72 Inflammatory disease of cervix uteri	0.005	0.995	0.000
R25.1 Tremor, unspecified	0.005	0.995	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.000	0.996	0.004
K56.7 Ileus, unspecified	0.004	0.996	0.000
M19.91 Arthrosis, unspecified (Shoulder region)	0.000	0.996	0.004
M47.92 Spondylosis, unspecified (Cervical region)	0.004	0.996	0.000
S42.00 Fracture of clavicle (closed)	0.000	0.996	0.004
E78.2 Mixed hyperlipidaemia	0.004	0.996	0.000
J86.9 Pyothorax without fistula	0.003	0.997	0.000
M20.2 Hallux rigidus	0.000	0.997	0.003
S51.0 Open wound of elbow	0.000	0.997	0.003
S42.0 Fracture of clavicle	0.000	0.997	0.003
R20 Disturbances of skin sensation	0.003	0.997	0.000
S51.9 Open wound of forearm, part unspecified	0.000	0.997	0.003
R20.0 Anaesthesia of skin	0.003	0.997	0.000
S52.60 Fracture of lower end of both ulna and radius (closed)	0.002	0.998	0.000
R25 Abnormal involuntary movements	0.002	0.998	0.000
S42.40 Fracture of lower end of humerus (closed)	0.000	0.998	0.002
S51 Open wound of forearm	0.000	0.998	0.002
N17-N19 Renal failure	0.002	0.998	0.000
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified	0.002	0.998	0.000
J86 Pyothorax	0.002	0.998	0.000
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Z94.0 Kidney transplant status	0.002	0.998	0.000
S42.01 Fracture of clavicle (open)	0.000	0.998	0.002
S42.20 Fracture of upper end of humerus (closed)	0.000	0.998	0.002
D25.2 Subserosal leiomyoma of uterus	0.002	0.998	0.000
R20.3 Hyperaesthesia	0.002	0.998	0.000
R20.1 Hypoaesthesia of skin	0.002	0.998	0.000
S42.4 Fracture of lower end of humerus	0.000	0.998	0.002
M48.06 Spinal stenosis (Lumbar region)	0.000	0.998	0.002
S42.2 Fracture of upper end of humerus	0.000	0.998	0.002
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.998	0.002
S42 Fracture of shoulder and upper arm	0.000	0.998	0.002
M48.09 Spinal stenosis (Site unspecified)	0.000	0.998	0.002
J86.0 Pyothorax with fistula	0.002	0.998	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.000
N17 Acute renal failure	0.002	0.998	0.000
G44.2 Tension-type headache	0.000	0.998	0.002
Y45.0 Opioids and related analgesics	0.002	0.998	0.000
S51.8 Open wound of other parts of forearm	0.000	0.998	0.002
R25.0 Abnormal head movements	0.002	0.998	0.000
S51.7 Multiple open wounds of forearm	0.000	0.998	0.002
R25.8 Other and unspecified abnormal involuntary movements	0.002	0.998	0.000
R25.2 Cramp and spasm	0.002	0.998	0.000
Z97.4 Presence of external hearing-aid	0.002	0.998	0.000
R25.3 Fasciculation	0.002	0.998	0.000
C83.7 Burkitt's tumour	0.002	0.998	0.000
Z89.5 Acquired absence of leg at or below knee	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
M21.26 Flexion deformity (Lower leg)	0.002	0.998	0.000
C83.3 Large cell (diffuse)	0.002	0.998	0.000
M48.0 Spinal stenosis	0.000	0.998	0.002
N17.9 Acute renal failure, unspecified	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
M21.16 Varus deformity, not elsewhere classified (Lower leg)	0.002	0.998	0.000
M13.00 Polyarthritis, unspecified (Multiple sites)	0.002	0.998	0.000
S42.41 Fracture of lower end of humerus (open)	0.000	0.998	0.002
J31.0 Chronic rhinitis	0.002	0.998	0.000
C83.1 Small cleaved cell (diffuse)	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.002	0.998	0.000
C90.0 Multiple myeloma	0.002	0.998	0.000
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.002	0.998	0.000
S42.21 Fracture of upper end of humerus (open)	0.000	0.998	0.002
C81.9 Hodgkin's disease, unspecified	0.002	0.998	0.000
D26.9 Uterus, unspecified	0.002	0.998	0.000
G51.0 Bell's palsy	0.000	0.998	0.002
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
S42.8 Fracture of other parts of shoulder and upper arm	0.000	0.998	0.002
S42.1 Fracture of scapula	0.000	0.998	0.002
C84 Peripheral and cutaneous T-cell lymphomas	0.002	0.998	0.000
C84.4 Peripheral T-cell lymphoma	0.002	0.998	0.000
S42.9 Fracture of shoulder girdle, part unspecified	0.000	0.998	0.002
C91.5 Adult T-cell leukaemia	0.002	0.998	0.000
K04.5 Chronic apical periodontitis	0.002	0.998	0.000
Z63.5 Disruption of family by separation and divorce	0.002	0.998	0.000
Z63.0 Problems in relationship with spouse or partner	0.002	0.998	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
N17.8 Other acute renal failure	0.002	0.998	0.000
N17.2 Acute renal failure with medullary necrosis	0.002	0.998	0.000
N17.1 Acute renal failure with acute cortical necrosis	0.002	0.998	0.000
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.000	0.998	0.002
Z63.8 Other specified problems related to primary support group	0.002	0.998	0.000
Z89.0 Acquired absence of finger(s) [including thumb], unilateral	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.002	0.998	0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.000	0.998	0.002
J32.0 Chronic maxillary sinusitis	0.000	0.998	0.002
Z89.2 Acquired absence of upper limb above wrist	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
C81 Hodgkin's disease	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
Z94.8 Other transplanted organ and tissue status	0.002	0.998	0.000
M48.00 Spinal stenosis (Multiple sites in spine)	0.000	0.998	0.002
C83.6 Undifferentiated (diffuse)	0.002	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.002	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.002	0.998	0.000
C83.2 Mixed small and large cell (diffuse)	0.002	0.998	0.000
J69.0 Pneumonitis due to food and vomit	0.002	0.998	0.000
Z89 Acquired absence of limb	0.002	0.998	0.000
M48.05 Spinal stenosis (Thoracolumbar region)	0.000	0.998	0.002
M48.04 Spinal stenosis (Thoracic region)	0.000	0.998	0.002
M48.03 Spinal stenosis (Cervicothoracic region)	0.000	0.998	0.002
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
D26.0 Cervix uteri	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
S42.7 Multiple fractures of clavicle, scapula and humerus	0.000	0.998	0.001
C90.2 Plasmacytoma, extramedullary	0.002	0.998	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.002	0.998	0.000
Z63 Other problems related to primary support group, including family circumstances	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.002	0.998	0.000
Z89.6 Acquired absence of leg above knee	0.002	0.998	0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.002	0.998	0.000
K70.3 Alcoholic cirrhosis of liver	0.000	0.998	0.002
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.001	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
S42.11 Fracture of scapula (open)	0.000	0.998	0.001
S42.81 Fracture of other parts of shoulder and upper arm (open)	0.000	0.998	0.001
S42.80 Fracture of other parts of shoulder and upper arm (closed)	0.000	0.998	0.001
C84.9 Mature T/NK-cell lymphoma, unspecified	0.001	0.998	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.001	0.998	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.001	0.998	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.001	0.998	0.000
C84.3 Lymphoepithelioid lymphoma	0.001	0.998	0.000
C84.2 T-zone lymphoma	0.001	0.998	0.000
C84.1 Sezary's diease	0.001	0.998	0.000
C84.0 Mycosis fungoides	0.001	0.998	0.000
N17.0 Acute renal failure with tubular necrosis	0.001	0.998	0.000
S42.3 Fracture of shaft of humerus	0.000	0.998	0.001
Y40.3 Macrolides	0.001	0.998	0.000
S42.10 Fracture of scapula (closed)	0.000	0.998	0.001
S42.91 Fracture of shoulder girdle, part unspecified (open)	0.000	0.998	0.001
C81.1 Nodular sclerosis	0.001	0.998	0.000
D26.1 Corpus uteri	0.002	0.998	0.000
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.002	0.998	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
Z89.9 Acquired absence of limb, unspecified	0.001	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
S42.90 Fracture of shoulder girdle, part unspecified (closed)	0.000	0.998	0.001
C90.3 Solitary plasmacytoma	0.001	0.998	0.000
C90.1 Plasma cell leukaemia	0.001	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.001	0.998	0.000
C81.7 Other Hodgkin's disease	0.001	0.998	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.001	0.998	0.000
C81.3 Lymphocytic depletion	0.001	0.998	0.000
C81.2 Mixed cellularity	0.001	0.998	0.000
C81.0 Lymphocytic predominance	0.001	0.998	0.000
W49.9 Unspecified place	0.001	0.998	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.000	0.998	0.002
C91.0 Acute lymphoblastic leukaemia	0.001	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.001	0.998	0.000
Y40.6 Rifamycins	0.001	0.998	0.000
Y40.5 Aminoglycosides	0.001	0.998	0.000
Y40.4 Tetracyclines	0.001	0.998	0.000
Y40.2 Chloramphenicol group	0.001	0.998	0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.000	0.998	0.001
C45.7 Mesothelioma of other sites	0.001	0.998	0.000
D22.7 Melanocytic naevi of lower limb, including hip	0.000	0.998	0.001
O63.0 Prolonged first stage (of labour)	0.000	0.998	0.001
S52.6 Fracture of lower end of both ulna and radius	0.001	0.998	0.000
Z63.4 Disappearance and death of family member	0.001	0.998	0.000
Z89.8 Acquired absence of upper and lower limbs [any level]	0.001	0.998	0.000
Z89.7 Acquired absence of both lower limbs [any level, except toes alone]	0.001	0.998	0.000
Z89.3 Acquired absence of both upper limbs [any level]	0.001	0.998	0.000
Z89.1 Acquired absence of hand and wrist	0.001	0.998	0.000
M23.80 Other internal derangements of knee (Multiple sites)	0.001	0.999	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.999	0.000
D26 Other benign neoplasms of uterus	0.001	0.999	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.001	0.999	0.000
S42.71 Multiple fractures of clavicle, scapula and humerus (open)	0.000	0.999	0.001
S52.61 Fracture of lower end of both ulna and radius (open)	0.001	0.999	0.000
Z63.9 Problem related to primary support group, unspecified	0.001	0.999	0.000
Z63.6 Dependent relative needing care at home	0.001	0.999	0.000
Z63.3 Absence of family member	0.001	0.999	0.000
Z63.2 Inadequate family support	0.001	0.999	0.000
Z63.1 Problems in relationship with parents and in-laws	0.001	0.999	0.000
Z89.4 Acquired absence of foot and ankle	0.001	0.999	0.000
Z99.2 Dependence on renal dialysis	0.001	0.999	0.000
N70-N77 Inflammatory diseases of female pelvic organs	0.001	0.999	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.001	0.999	0.000
C91.7 Other lymphoid leukaemia	0.001	0.999	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.001	0.999	0.000
C91.3 Prolymphocytic leukaemia	0.001	0.999	0.000
C91.2 Subacute lymphocytic leukaemia	0.001	0.999	0.000
J92.0 Pleural plaque with presence of asbestos	0.001	0.999	0.000
Z63.7 Other stressful life events affecting family and household	0.001	0.999	0.000
C91.9 Lymphoid leukaemia, unspecified	0.001	0.999	0.000
H25.8 Other senile cataract	0.001	0.999	0.000
D80 Immunodeficiency with predominantly antibody defects	0.001	0.999	0.000
S42.31 Fracture of shaft of humerus (open)	0.000	0.999	0.001
M23.8 Other internal derangements of knee	0.001	0.999	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.001	0.999	0.000
Y54.5 Other diuretics	0.001	0.999	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
C95 Leukaemia of unspecified cell type	0.001	0.999	0.000
C94 Other leukaemias of specified cell type	0.001	0.999	0.000
C93 Monocytic leukaemia	0.001	0.999	0.000
C86 Other specified types of T/NK-cell lymphoma	0.001	0.999	0.000
C45.0 Mesothelioma of pleura	0.001	0.999	0.000
N76.4 Abscess of vulva	0.001	0.999	0.000
Y41.5 Antiviral drugs	0.001	0.999	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.999	0.000
Y54.7 Agents affecting calcification	0.001	0.999	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.999	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.999	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.999	0.000
Y54.0 Mineralocorticoids	0.001	0.999	0.000
Y57 Other and unspecified drugs and medicaments	0.001	0.999	0.000
M21.2 Flexion deformity	0.001	0.999	0.000
O64.1 Obstructed labour due to breech presentation	0.000	0.999	0.001
N70 Salpingitis and oophoritis	0.001	0.999	0.000
M47.9 Spondylosis, unspecified	0.001	0.999	0.000
Y44.5 Thrombolytic drugs	0.001	0.999	0.000
C45.9 Mesothelioma, unspecified	0.001	0.999	0.000
D26.7 Other parts of uterus	0.001	0.999	0.000
G24.8 Other dystonia	0.001	0.999	0.000
M21.1 Varus deformity, not elsewhere classified	0.001	0.999	0.000
Y59 Other and unspecified vaccines and biological substances	0.001	0.999	0.000
Y58 Bacterial vaccines	0.001	0.999	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.999	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.001	0.999	0.000
Y48 Anaesthetics and therapeutic gases	0.001	0.999	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.999	0.000
S42.70 Multiple fractures of clavicle, scapula and humerus (closed)	0.000	0.999	0.001
C91.1 Chronic lymphocytic leukaemia	0.001	0.999	0.000
I86.4 Gastric varices	0.000	0.999	0.001
K86.8 Other specified diseases of pancreas	0.001	0.999	0.000
C45 Mesothelioma	0.001	0.999	0.000
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.001	0.999	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.001	0.999	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.001	0.999	0.000
C83.0 Small cell (diffuse)	0.001	0.999	0.000
C91.4 Hairy-cell leukaemia	0.001	0.999	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.001	0.999	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.001	0.999	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.001	0.999	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.001	0.999	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.001	0.999	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.001	0.999	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.001	0.999	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.001	0.999	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.001	0.999	0.000
G24.5 Blepharospasm	0.001	0.999	0.000
T80.8 Other complications following infusion, transfusion and therapeutic injection	0.000	0.999	0.001
O64 Obstructed labour due to malposition and malpresentation of foetus	0.000	0.999	0.001
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.001	0.999	0.000
Z94 Transplanted organ and tissue status	0.001	0.999	0.000
M23.87 Other internal derangements of knee (Capsular ligament)	0.001	0.999	0.000
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)	0.001	0.999	0.000
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.001	0.999	0.000
N70.0 Acute salpingitis and oophoritis	0.001	0.999	0.000
N76.8 Other specified inflammation of vagina and vulva	0.001	0.999	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.999	0.000
Y41.4 Anthelminthics	0.001	0.999	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.999	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.999	0.000
Y41.1 Antimycobacterial drugs	0.001	0.999	0.000
Y41.0 Sulphonamides	0.001	0.999	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.999	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.001	0.999	0.000
N73 Other female pelvic inflammatory diseases	0.001	0.999	0.000
M21.27 Flexion deformity (Ankle and foot)	0.001	0.999	0.000
M23.82 Other internal derangements of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.001	0.999	0.000
C16.9 Stomach, unspecified	0.001	0.999	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.999	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.001	0.999	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.999	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.001	0.999	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.001	0.999	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.001	0.999	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.001	0.999	0.000
C93.9 Monocytic leukaemia, unspecified	0.001	0.999	0.000
C93.7 Other monocytic leukaemia	0.001	0.999	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.001	0.999	0.000
C93.2 Subacute monocytic leukaemia	0.001	0.999	0.000
C93.1 Chronic monocytic leukaemia	0.001	0.999	0.000
C93.0 Acute monocytic leukaemia	0.001	0.999	0.000
C94.7 Other specified leukaemias	0.001	0.999	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.999	0.000
C94.5 Acute myelofibrosis	0.001	0.999	0.000
C94.4 Acute panmyelosis	0.001	0.999	0.000
C94.3 Mast cell leukaemia	0.001	0.999	0.000
C94.2 Acute megakaryoblastic leukaemia	0.001	0.999	0.000
C94.1 Chronic erythraemia	0.001	0.999	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.001	0.999	0.000
C95.9 Leukaemia, unspecified	0.001	0.999	0.000
C95.7 Other leukaemia of unspecified cell type	0.001	0.999	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.001	0.999	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.001	0.999	0.000
C95.0 Acute leukaemia of unspecified cell type	0.001	0.999	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.001	0.999	0.000
C96.8 Histiocytic sarcoma	0.001	0.999	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.001	0.999	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.001	0.999	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.001	0.999	0.000
C96.3 True histiocytic lymphoma	0.001	0.999	0.000
C96.2 Malignant mast cell tumour	0.001	0.999	0.000
C96.1 Malignant histiocytosis	0.001	0.999	0.000
C96.0 Letterer-Siwe disease	0.001	0.999	0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.000	0.999	0.001
O66.0 Obstructed labour due to shoulder dystocia	0.000	0.999	0.001
T78.2 Anaphylactic shock, unspecified	0.000	0.999	0.001
Y40.0 Penicillins	0.001	0.999	0.000
Y57.7 Vitamins, not elsewhere classified	0.001	0.999	0.000
Y57.6 Other diagnostic agents	0.001	0.999	0.000
Y57.4 Pharmaceutical excipients	0.001	0.999	0.000
Y57.3 Alcohol deterrents	0.001	0.999	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.001	0.999	0.000
Y57.1 Lipotropic drugs	0.001	0.999	0.000
Y57.0 Appetite depressants [anorectics]	0.001	0.999	0.000
C88 Malignant immunoproliferative diseases	0.001	0.999	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.001	0.999	0.000
Y44 Agents primarily affecting blood constituents	0.001	0.999	0.000
M21.29 Flexion deformity (Site unspecified)	0.001	0.999	0.000
M21.28 Flexion deformity (Other)	0.001	0.999	0.000
M21.25 Flexion deformity (Pelvic region and thigh)	0.001	0.999	0.000
M21.23 Flexion deformity (Forearm)	0.001	0.999	0.000
M21.22 Flexion deformity (Upper arm)	0.001	0.999	0.000
M21.21 Flexion deformity (Shoulder region)	0.001	0.999	0.000
M21.20 Flexion deformity (Multiple sites)	0.001	0.999	0.000
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.001	0.999	0.000
Q89.2 Congenital malformations of other endocrine glands	0.001	0.999	0.000
N76 Other inflammation of vagina and vulva	0.001	0.999	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.001	0.999	0.000
M47.94 Spondylosis, unspecified (Thoracic region)	0.001	0.999	0.000
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.001	0.999	0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.001	0.999	0.000
G25.3 Myoclonus	0.001	0.999	0.000
Y40.9 Systemic antibiotic, unspecified	0.001	0.999	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.999	0.000
Y43.4 Immunosuppressive agents	0.001	0.999	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.999	0.000
C92 Myeloid leukaemia	0.001	0.999	0.000
V18 Pedal cyclist injured in noncollision transport accident	0.001	0.999	0.000
M21.19 Varus deformity, not elsewhere classified (Site unspecified)	0.001	0.999	0.000
M21.18 Varus deformity, not elsewhere classified (Other)	0.001	0.999	0.000
M21.15 Varus deformity, not elsewhere classified (Pelvic region and thigh)	0.001	0.999	0.000
M21.14 Varus deformity, not elsewhere classified (Hand)	0.001	0.999	0.000
M21.13 Varus deformity, not elsewhere classified (Forearm)	0.001	0.999	0.000
M21.12 Varus deformity, not elsewhere classified (Upper arm)	0.001	0.999	0.000
M21.11 Varus deformity, not elsewhere classified (Shoulder region)	0.001	0.999	0.000
M21.10 Varus deformity, not elsewhere classified (Multiple sites)	0.001	0.999	0.000
M54.22 Cervicalgia (Cervical region)	0.001	0.999	0.000
C45.2 Mesothelioma of pericardium	0.001	0.999	0.000
C45.1 Mesothelioma of peritoneum	0.001	0.999	0.000
D86.1 Sarcoidosis of lymph nodes	0.001	0.999	0.000
H93.1 Tinnitus	0.000	0.999	0.001
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere	0.001	0.999	0.000
N74.4 Female chlamydial pelvic inflammatory disease	0.001	0.999	0.000
N74.3 Female gonococcal pelvic inflammatory disease	0.001	0.999	0.000
N74.2 Female syphilitic pelvic inflammatory disease	0.001	0.999	0.000
N74.1 Female tuberculous pelvic inflammatory disease	0.001	0.999	0.000
N74.0 Tuberculous infection of cervix uteri	0.001	0.999	0.000
Y46.8 Antispasticity drugs	0.001	0.999	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.999	0.000
Y46.6 Other and unspecified antiepileptics	0.001	0.999	0.000
Y46.5 Valproic acid	0.001	0.999	0.000
Y46.4 Iminostilbenes	0.001	0.999	0.000
Y46.3 Deoxybarbiturates	0.001	0.999	0.000
Y46.2 Hydantoin derivatives	0.001	0.999	0.000
Y46.1 Oxazolidinediones	0.001	0.999	0.000
Y46.0 Succinimides	0.001	0.999	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.999	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.999	0.000
Y47.4 Bromine compounds	0.001	0.999	0.000
Y47.3 Paraldehyde	0.001	0.999	0.000
Y47.2 Chloral derivatives	0.001	0.999	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.999	0.000
Y48.5 Therapeutic gases	0.001	0.999	0.000
Y48.4 Anaesthetic, unspecified	0.001	0.999	0.000
Y48.2 Other and unspecified general anaesthetics	0.001	0.999	0.000
Y48.1 Parenteral anaesthetics	0.001	0.999	0.000
Y48.0 Inhaled anaesthetics	0.001	0.999	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.999	0.000
Y50.8 Other central nervous system stimulants	0.001	0.999	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.999	0.000
Y50.1 Opioid receptor antagonists	0.001	0.999	0.000
Y50.0 Analeptics	0.001	0.999	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.999	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.999	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.999	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.999	0.000
Y51.0 Anticholinesterase agents	0.001	0.999	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.999	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y53.7 Emetics	0.001	0.999	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.999	0.000
Y53.5 Digestants	0.001	0.999	0.000
Y53.4 Other laxatives	0.001	0.999	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.999	0.000
Y53.2 Stimulant laxatives	0.001	0.999	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.999	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.999	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.999	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
Y55.5 Anticommon cold drugs	0.001	0.999	0.000
Y55.4 Expectorants	0.001	0.999	0.000
Y55.3 Antitussives	0.001	0.999	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.001	0.999	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.999	0.000
Y55.0 Oxytocic drugs	0.001	0.999	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.999	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.999	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.999	0.000
Y58.5 Diphtheria vaccine	0.001	0.999	0.000
Y58.4 Tetanus vaccine	0.001	0.999	0.000
Y58.3 Plague vaccine	0.001	0.999	0.000
Y58.2 Cholera vaccine	0.001	0.999	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.001	0.999	0.000
Y58.0 BCG vaccine	0.001	0.999	0.000
Y59.9 Vaccine or biological substance, unspecified	0.001	0.999	0.000
Y59.8 Other specified vaccines and biological substances	0.001	0.999	0.000
Y59.3 Immunoglobulin	0.001	0.999	0.000
Y59.2 Protozoal vaccines	0.001	0.999	0.000
Y59.1 Rickettsial vaccines	0.001	0.999	0.000
Y59.0 Viral vaccines	0.001	0.999	0.000
Z43.3 Attention to colostomy	0.000	0.999	0.001
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.000	0.999	0.001
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.001	0.999	0.000
C92.1 Chronic myeloid leukaemia	0.001	0.999	0.000
J85.2 Abscess of lung without pneumonia	0.001	0.999	0.000
O64.9 Obstructed labour due to malposition and malpresentation, unspecified	0.000	0.999	0.001
O64.8 Obstructed labour due to other malposition and malpresentation	0.000	0.999	0.001
O64.5 Obstructed labour due to compound presentation	0.000	0.999	0.001
O64.4 Obstructed labour due to shoulder presentation	0.000	0.999	0.001
O64.3 Obstructed labour due to brow presentation	0.000	0.999	0.001
O64.2 Obstructed labour due to face presentation	0.000	0.999	0.001
Q07.0 Arnold-Chiari syndrome	0.001	0.999	0.000
Y48.3 Local anaesthetics	0.001	0.999	0.000
Y56.9 Topical agent, unspecified	0.001	0.999	0.000
Y56.8 Other topical agents	0.001	0.999	0.000
Y56.7 Dental drugs, topically applied	0.001	0.999	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.999	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.999	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.999	0.000
Y56.3 Emollients, demulcents and protectants	0.001	0.999	0.000
Y56.2 Local astringents and local detergents	0.001	0.999	0.000
Y56.1 Antipruritics	0.001	0.999	0.000
Z94.9 Transplanted organ and tissue status, unspecified	0.001	0.999	0.000
Z94.6 Bone transplant status	0.001	0.999	0.000
Z94.5 Skin transplant status	0.001	0.999	0.000
Z94.3 Heart and lungs transplant status	0.001	0.999	0.000
Z94.2 Lung transplant status	0.001	0.999	0.000
Z94.1 Heart transplant status	0.001	0.999	0.000
W49 Exposure to other and unspecified inanimate mechanical forces	0.001	0.999	0.000
M80.52 Idiopathic osteoporosis with pathological fracture (Upper arm)	0.001	0.999	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.001	0.999	0.000
N73.5 Female pelvic peritonitis, unspecified	0.001	0.999	0.000
N73.4 Female chronic pelvic peritonitis	0.001	0.999	0.000
N73.3 Female acute pelvic peritonitis	0.001	0.999	0.000
N73.2 Unspecified parametritis and pelvic cellulitis	0.001	0.999	0.000
N73.1 Chronic parametritis and pelvic cellulitis	0.001	0.999	0.000
N73.0 Acute parametritis and pelvic cellulitis	0.001	0.999	0.000
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere	0.001	0.999	0.000
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
Y43.0 Antiallergic and antiemetic drugs	0.001	0.999	0.000
Y47.1 Benzodiazepines	0.001	0.999	0.000
J85 Abscess of lung and mediastinum	0.001	0.999	0.000
M84.03 Malunion of fracture (Forearm)	0.001	0.999	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.001	0.999	0.000
C88.7 Other malignant immunoproliferative diseases	0.001	0.999	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.001	0.999	0.000
C88.3 Immunoproliferative small intestinal disease	0.001	0.999	0.000
C88.2 Gamma heavy chain disease	0.001	0.999	0.000
C88.1 Alpha heavy chain disease	0.001	0.999	0.000
K29.0 Acute haemorrhagic gastritis	0.000	0.999	0.001
N76.5 Ulceration of vagina	0.001	0.999	0.000
N76.1 Subacute and chronic vaginitis	0.001	0.999	0.000
X50.2 School, other institution and public administrative area	0.001	0.999	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations